Back to Search
VICTOR MATTHEWS, M.D.
M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1457363541IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
ME93340(FL)
CMS Specialties
PrimaryENDOCRINOLOGY
Education
UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE
Class of 1993
Research & Publications (20)
Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression.
PMID 19188427·Diabetes·2009
7-preclinical
gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.
PMID 19185844·Cancer Cell·2009
7-preclinical
Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase.
PMID 19387610·Diabetologia·2009
7-preclinical
PCDD/Fs and PCBs in seafood species from Moreton Bay, Queensland, Australia.
PMID 18321534·Mar Pollut Bull·2008
7-preclinical
CNTF: a target therapeutic for obesity-related metabolic disease?
PMID 18210031·J Mol Med (Berl)·2008
6-review
IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice.
PMID 18156493·Blood·2008
7-preclinical
Flame retardants (PBDEs) in marine turtles, dugongs and seafood from Queensland, Australia.
PMID 18313081·Mar Pollut Bull·2008
7-preclinical
STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
PMID 18431520·J Clin Invest·2008
7-preclinical
BDNF, metabolic risk factors, and resistance training in middle-aged individuals.
PMID 18379218·Med Sci Sports Exerc·2008
2-rct
Opposing roles of gp130-mediated STAT-3 and ERK-1/ 2 signaling in liver progenitor cell migration and proliferation.
PMID 17256754·Hepatology·2007
7-preclinical
ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro.
PMID 17210715·Cancer Res·2007
8-other
Attenuated liver progenitor (oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred strain of mice.
PMID 17112626·J Hepatol·2007
7-preclinical
Jekyll and Hyde: evolving perspectives on the function and potential of the adult liver progenitor (oval) cell.
PMID 16237666·Bioessays·2005
6-review
Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury.
PMID 16033531·Immunol Cell Biol·2005
7-preclinical
Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.
PMID 15878349·Exp Cell Res·2005
7-preclinical
Differential lymphotoxin-beta and interferon gamma signaling during mouse liver regeneration induced by chronic and acute injury.
PMID 15660390·Hepatology·2005
7-preclinical
Genetic manipulations utilizing albumin and alpha-fetoprotein promoter/enhancers affect both hepatocytes and oval cells.
PMID 15349917·Hepatology·2004
7-preclinical
Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE).
PMID 12832423·J Biol Chem·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 213 S DILLARD ST STE 120
WINTER GARDEN, FL 34787 - Phone
- (407) 614-1644
Quick Facts
- NPI
- 1457363541
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile